Listed

Argenx SE: Form 20-F for the period ended Dec 31, 2025

Filed with the SEC on Mar 19, 2026 and accepted by EDGAR at Mar 19, 2026, 06:13 ET.

Share

Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2025-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Cost of revenue12 months2025-01-01 to 2025-12-31$450.7mifrs-full:CostOfSales
Operating income12 months2025-01-01 to 2025-12-31$1.05bnifrs-full:ProfitLossFromOperatingActivities
Income tax12 months2025-01-01 to 2025-12-31−$13.4mifrs-full:IncomeTaxExpenseContinuingOperations
Net income12 months2025-01-01 to 2025-12-31$1.29bnifrs-full:ProfitLossAttributableToOwnersOfParent
Diluted EPS12 months2025-01-01 to 2025-12-31$19.57ifrs-full:DilutedEarningsLossPerShare
Basic EPS12 months2025-01-01 to 2025-12-31$21.08ifrs-full:BasicEarningsLossPerShare
Operating cash flow12 months2025-01-01 to 2025-12-31$685.2mifrs-full:CashFlowsFromUsedInOperatingActivities
Capital expenditure12 months2025-01-01 to 2025-12-31$6.2mifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
Cash and equivalentsAt period end2025-12-31$3.49bnifrs-full:CashAndCashEquivalents
Current assetsAt period end2025-12-31$6.90bnifrs-full:CurrentAssets
Total assetsAt period end2025-12-31$8.68bnifrs-full:Assets
Current liabilitiesAt period end2025-12-31$1.32bnifrs-full:CurrentLiabilities
Total liabilitiesAt period end2025-12-31$1.36bnifrs-full:Liabilities
Shareholders' equityAt period end2025-12-31$7.32bnifrs-full:Equity
Shares outstandingAt period end2025-12-3161,883,306 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0001697862-26-000032. Last ingested by Listed: Nov 9, 2026, 17:48 ET. Listed shows no prices and gives no investment advice.